Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05416983 · ClinicalTrials.gov registry record
Developing a Shared Decision Making Tool for Patients With Surgically Removed Non-small Cell Lung Cancer
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 37
- Enrollment target
NCT05416983: Completed study, sponsored by Mayo Clinic.
NCT05416983 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 37 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05416983 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 37 participants
- Enrollment target
Study Summary
This study observes conversations between non-small cell lung cancer patients and their doctors to support the development of a decision aid that can be used to inform discussions about treatment options for after surgery. Patients who have undergone surgery for their non-small cell lung cancer may have the option of completing additional treatment. Patients contemplating this additional treatment have been shown to be most satisfied with their choice if they perceive an effort by their doctor to share decision making. Shared decision making tools can help doctors guide conversations, offer tailored recommendations, and support deliberation on whether or not to pursue treatment. This study develops a shared decision making tool for patients with surgically removed non-small cell lung cancer contemplating additional treatment.
Interventions
- OTHER Questionnaire Administration
- PROCEDURE Discussion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2022-02-17 |
| Est. Completion | 2023-08-31 |
What the finished NCT05416983 record still lists
NCT05416983 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 37 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Questionnaire Administration is the first listed.
NCT05416983 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05416983 about?
NCT05416983 is a clinical study titled "Developing a Shared Decision Making Tool for Patients With Surgically Removed Non-small Cell Lung Cancer". This study observes conversations between non-small cell lung cancer patients and their doctors to support the development of a decision aid that can be used to inform discussions about treatment options for after surgery. Patients who have undergone surgery for their non-small cell lung cancer may ...
What is the current status of trial NCT05416983?
This trial is currently completed. The enrollment target is 37 participants. The study started on 2022-02-17. Estimated completion is 2023-08-31.
What interventions are being tested in trial NCT05416983?
The interventions under investigation include: Questionnaire Administration (OTHER), Discussion (PROCEDURE).
Who is sponsoring clinical trial NCT05416983?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI